Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126412611 | 12641261 | 1 | I | 201605 | 20160727 | 20160810 | 20160810 | PER | US-PFIZER INC-2016364428 | PFIZER | 54.00 | YR | M | Y | 97.00000 | KG | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126412611 | 12641261 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 600 MG, 2X/DAY | 20882 | 600 | MG | FILM-COATED TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126412611 | 12641261 | 1 | Diabetic neuropathy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126412611 | 12641261 | Drug ineffective for unapproved indication | |
| 126412611 | 12641261 | Eating disorder | |
| 126412611 | 12641261 | Gait disturbance | |
| 126412611 | 12641261 | Pain in extremity | |
| 126412611 | 12641261 | Pre-existing condition improved | |
| 126412611 | 12641261 | Therapeutic response unexpected | |
| 126412611 | 12641261 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |